These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6364486)

  • 21. The effect of timing of skin grafts on subsequent survival in ALS-treated, marrow-infused mice.
    Wood ML; Monaco AP
    Transplantation; 1977 Jan; 23(1):78-86. PubMed ID: 65036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse skin graft prolongation with donor strain bone marrow and anti-lymphocyte serum: surface markers of the active bone marrow cells.
    De Fazio S; Hartner WC; Monaco AP; Gozzo JJ
    J Immunol; 1985 Nov; 135(5):3034-8. PubMed ID: 2864375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of permanent mixed chimerism and skin allograft tolerance across fully MHC-mismatched barriers by the additional myelosuppressive treatments in mice primed with allogeneic spleen cells followed by cyclophosphamide.
    Tomita Y; Yoshikawa M; Zhang QW; Shimizu I; Okano S; Iwai T; Yasui H; Nomoto K
    J Immunol; 2000 Jul; 165(1):34-41. PubMed ID: 10861032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression.
    Oluwole SF; Jin MX; Chowdhury NC; Ohajekwe OA
    Transplantation; 1994 Nov; 58(10):1077-81. PubMed ID: 7974714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of induction of unresponsiveness to class I antigens by veto activity of donor marrow in cylophosphamide-treated mice.
    Tomita Y; Nomoto K
    Transplantation; 1993 Dec; 56(6):1473-80. PubMed ID: 8279022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
    Gozzo JJ; Wood ML; Pompei R; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of granulocyte-macrophage colony-stimulating factor on the induction of unresponsiveness by lymphoid cells.
    Monaco AP; Wood ML; Gottschalk R; Seiler FR
    Transplantation; 1991 Jan; 51(1):213-8. PubMed ID: 1670970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerance induction using autologous bone marrow modified with an allogeneic class I MHC gene.
    Sachs DH; Bodine DM; Moulton AD; Pearson DA; Nienhuis AW; Sykes M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):348-9. PubMed ID: 8438329
    [No Abstract]   [Full Text] [Related]  

  • 30. Fetal pancreas allografts for reversal of diabetes in rats. II. Induction of life-term-specific unresponsiveness to pancreas allografts across nonmajor histocompatibility complex barriers.
    Mullen Y; Shintaku IP
    Transplantation; 1982 Jan; 33(1):3-11. PubMed ID: 7039021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppressor cells in specific unresponsiveness to skin allografts in thymectomized, ALS-treated, marrow-injected mice.
    Wood ML; Gottschalk R; Monaco AP
    Transplantation; 1979 Nov; 28(5):387-8. PubMed ID: 160636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes.
    Madsen JC; Superina RA; Wood KJ; Morris PJ
    Nature; 1988 Mar; 332(6160):161-4. PubMed ID: 3279318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerance of skin allografts incompatible at the entire H-2 complex induced in adult mice by the post-transplant treatment.
    Chutná J; Holán V; Sládecek M; Hasek M
    Folia Biol (Praha); 1986; 32(2):154-8. PubMed ID: 3522287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of pharmacologic immunosuppression to augment the specific unresponsiveness (tolerance) to skin allografts induced by donor-specific bone marrow in antilymphocyte serum-treated mice: the unique effect of sirolimus.
    Hale D; Gottschalk R; Maki T; Monaco AP
    Transplant Proc; 1998 Aug; 30(5):2432-4. PubMed ID: 9723527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of antigen-specific unresponsiveness to pancreatic islet allografts by antilymphocyte serum.
    Gotoh M; Porter J; Monaco AP; Maki T
    Transplantation; 1988 Feb; 45(2):429-33. PubMed ID: 2449750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerogenic behavior of skin allografts from neonatal mice.
    Markees TG; De Fazio SR; Gozzo JJ
    Transplantation; 1994 Nov; 58(9):1008-14. PubMed ID: 7974727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged survival of mouse skin allografts after transplantation of fetal liver cells transduced with hIL-10 gene.
    Sembeil R; Sanhadji K; Vivier G; Chargui J; Touraine JL
    Transpl Immunol; 2004; 13(1):1-8. PubMed ID: 15203122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adoptive transfer of specific unresponsiveness to skin allografts by spleen cells from ALS-treated, marrow-injected mice.
    Wood ML; Monaco AP
    Transplant Proc; 1979 Mar; 11(1):1023-7. PubMed ID: 377604
    [No Abstract]   [Full Text] [Related]  

  • 39. Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of a fully allogeneic cardiac allograft.
    Wong W; Morris PJ; Wood KJ
    Transplantation; 1996 Nov; 62(10):1462-8. PubMed ID: 8958273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion.
    Tomita Y; Nishimura Y; Harada N; Eto M; Ayukawa K; Yoshikai Y; Nomoto K
    J Immunol; 1990 Dec; 145(12):4026-36. PubMed ID: 2147933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.